One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients

BACKGROUND: It is unknown whether contemporary drug‐eluting stents have a similar safety profile in high bleeding risk patients treated with 1‐month dual antiplatelet therapy following percutaneous coronary interventions. METHODS AND RESULTS: We performed an interventional, prospective, multicenter,...

Descripción completa

Detalles Bibliográficos
Autores principales: Pivato, Carlo A., Reimers, Bernhard, Testa, Luca, Pacchioni, Andrea, Briguori, Carlo, Musto, Carmine, Esposito, Giovanni, Piccolo, Raffaele, Lucisano, Luigi, De Luca, Leonardo, Conrotto, Federico, De Marco, Andrea, Franzone, Anna, Presbitero, Patrizia, Ferrante, Giuseppe, Condorelli, Gerolama, Paradies, Valeria, Sardella, Gennaro, Indolfi, Ciro, Condorelli, Gianluigi, Stefanini, Giulio G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075308/
https://www.ncbi.nlm.nih.gov/pubmed/35114814
http://dx.doi.org/10.1161/JAHA.121.023454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075308/
https://www.ncbi.nlm.nih.gov/pubmed/35114814
http://dx.doi.org/10.1161/JAHA.121.023454

Ejemplares similares